1-Bromo-2-methylbutane | CAS:10422-35-2

We serve 1-Bromo-2-methylbutane CAS:10422-35-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-2-methylbutane

Chemical Name:1-Bromo-2-methylbutane
CAS.NO:10422-35-2
Synonyms:1-Bromo-2-methylbutane
Molecular Formula:C5H11Br
Molecular Weight:151.04500
 
Physical and Chemical Properties:
Density:1.460;
Melting point:-118.6oC;
Boiling point:38.4oC;
Flash point:-23oC;
Index of Refraction:1.424;
 
Specification:
Appearance:Colorless clear liquid
Purity:≥98.0%
Moisture:≤0.1%
Non-volatile:≤20ppm
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Synthesis:Prepared by reacting 2-methylbutanol with hydrobromic acid or sodium bromide
Application:Applicationd as an intermediate in organic synthesis



Contact us for information like 1-Bromo-2-methylbutane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Bromo-2-methylbutane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-2-methylbutane Use and application,1-Bromo-2-methylbutane technical grade,usp/ep/jp grade.


Related News: In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.2-Bromo-5-fluorotoluene manufacturer In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester supplier The fine and functional chemicals sector provides new growth drivers.6-Bromo-1,2,4-triazin-3-amine vendor The fine and functional chemicals sector provides new growth drivers.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.